Loading...
Back to narrative

EXPO: AI-Driven Demand Will Drive Future Engagements Despite Automation Headwinds

Update shared on 01 Dec 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-21.0%
7D
0.6%

Analysts have revised Exponent's price target downward by $10 to $90 per share, citing potential opportunities from AI-driven engagements as well as industry headwinds related to automation efficiencies.

Analyst Commentary

Following the recent revision to Exponent's price target, analysts have highlighted both opportunities and risks facing the company in today's evolving market landscape.

Bullish Takeaways

  • Bullish analysts see potential for artificial intelligence to drive new client engagements, particularly in areas such as failure analysis.
  • The company's reputation as a go-to firm for complex problem solving may help it maintain a strong pipeline, even as the consulting industry shifts.
  • Valuation is supported by the potential for Exponent to capture AI-driven demand as clients increasingly seek technologically advanced solutions.
  • Ongoing demand from existing clients could support stable revenue streams and operational execution, even with industry changes underway.

Bearish Takeaways

  • Bearish analysts caution that automation efficiencies could reduce the number of billable hours, which could potentially impact revenue growth.
  • The consulting industry's broader shift toward automation may continue to weigh on Exponent's growth prospects and execution over time.
  • Despite the opportunity in AI, headwinds from increased efficiency could offset some of the incremental demand the company expects.
  • There is concern that reliance on traditional consulting models may limit Exponent's ability to fully adapt to technology-driven changes in client needs.

What's in the News

  • Truist lowered Exponent's price target to $90 from $100, maintaining a Buy rating. The firm cited both AI potential and industry headwinds related to automation efficiencies. (Periodical)
  • The company announced an increase of $100 million to its equity buyback program, raising the total authorized repurchase amount to $736.7 million. (Key Developments)
  • Exponent completed the repurchase of over 11.2 million shares, totaling $613.96 million since May 2007. Recent tranche repurchases amounted to more than 560,000 shares for $40.06 million. (Key Developments)
  • Exponent provided new earnings guidance for the fourth quarter and full fiscal year 2025. The company is expecting low to mid-single digit revenue growth for the quarter and is maintaining low single-digit revenue growth guidance for the year. (Key Developments)

Valuation Changes

  • Fair Value Estimate is unchanged at $83 per share.
  • Discount Rate has risen slightly from 7.18% to 7.20%.
  • Revenue Growth has fallen slightly from 7.01% to 6.98% year-over-year.
  • Net Profit Margin has decreased modestly from 20.01% to 19.84%.
  • Future P/E Ratio has increased from 36.88x to 37.25x.

Have other thoughts on Exponent?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.